期刊文献+

扶素康的固相化学合成 被引量:1

Synthesis of Fusukang by solid-phase synthesis
在线阅读 下载PDF
导出
摘要 研究了36肽扶素康的9-芴甲氧羰基(Fmoc)法固相化学合成,包括Fmoc固相逐步化学合成和Fmoc固相片断缩合化学合成。在片段缩合中,研究了多肽片断的分段策略、片断缩合溶剂、片断缩合剂对片断缩合法合成扶素康质量的影响,确立了优化的片段缩合工艺条件为:将扶素康按残基1~10、11~20、21~25、26~36分作4段;以王树脂为固相载体;HATU/HOAt/DIEA为缩合剂(4倍过量);DMF/DCM(1:1)为反应溶剂;每步加入的全保护肽段为1.5倍过量;缩合及脱保护完成后以DCM为洗涤溶剂洗涤5次,进行固相片段缩合反应。该条件下合成的扶素康,粗品收率达67.31%,按标准曲线定量分析其纯度达38.75%。 9-Fluorenyl methoxy carbonyl (Fmoc) solid-phase synthesis of Fusukang was studied firstly, including stepwise solid-phase peptide synthesis (SPPS) and solid-phase convergent synthesis. The SPPS methodology utilized DMF as the coupling solvent, HBTU/HOBt/DIEA as the coupling reagent, Wang resin as solid supporter, TFA/p-methyl phenol/EDT/H2O (97 : 0.25 : 0.25: 2.5) as the cleavage condition, with 2-fold equivalent molar excess of protected amino acid. In the Fmoc solid-phase convergent synthesis of Fusukang, the effects of convergent protocol, coupling solvents, and coupling reagents on the yield of Fusukang were systemically studied, and the protocol of condensation process was optimized, i. e. using the sequential condensation of four protected peptide segments (1-10, 11-20, 21-25, 26-36) with 1.5-fold equivalent molar excess of protected peptide segments in solvent; HATU/HOAt/DIEA (4-fold equivalent) as the coupling reagent; mixture DMF/DCM (1 : 1, vol) as the coupling solvent; TFA/p-methyl phenol/EDT/H20 (97 : 0.25 : 0.25 :2.5) as the cleavage condition, washing resin 5 times with DCM before and after each reaction. The yield of crude Fusukang was 67.31% , and the purity was 38. 75 %.
出处 《化工学报》 EI CAS CSCD 北大核心 2007年第1期200-204,共5页 CIESC Journal
基金 天津市自然科学基金项目(993804311)~~
关键词 扶素康 固相多肽合成 片段缩合 Fusukang solid-phase peptide synthesis (SPPS) convergent synthesis
  • 相关文献

参考文献8

  • 1Jiang Shibo,Asim K Debnath.Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.Biochemicsl and Biophysical Research Cummunications,2000,269:641-646
  • 2Zhou Genfa(周根发),Tian Wangni(田望霓).A new drug to control the infection of HIV and it's combinations and their use:CN,01130985.7.2001-8-29
  • 3Barany G,Merrifield R B.Soliphase peptide synthesis//Gross E,Meienhofer J.The Peptides.New York:Academic Press,1980:37-39
  • 4Fujii N,Ikemura O,Funakoshi S,et al.Studies on peptides CLII.Hard acid deprotecting procedure for peptide synthesis.Chem.Pharm.Bull.,1987,35:3447-3452
  • 5White.Expediting Fmoc SPPS of long peptides.J.Peptide Sci.,2004,10:18-26
  • 6Konrad H Bleicher,Christian Lutxz,Yves Wuethrich.New phenylfluorenyl based linkers for solid phase synthesis.Tetrahedron Letters,2000,41:9037-9042
  • 7Paul Schimmel.The protein synthesis world.Trends in Biochemical Sciences,2002,27(10):505-506
  • 8Dimitrios Gatos,Stella Patrianakou,Olga Hatzi,et al.Comparison of the stepwise and convergent approaches in the solid-phase synthesis of rat Tyr0-atriopeptinⅡ.Letters in Peptide Science,1997,4:177-184

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部